JIC
APYX icon

Joel Isaacson & Co’s Apyx Medical APYX Stock Holding History

Joel Isaacson & Co’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92K Hold
20,500
– – ﹤0.01% 475
2026
Q1 		$75.6K Hold
20,500
– – ﹤0.01% 448
2025
Q4 		$71.8K Hold
20,500
– – ﹤0.01% 454
2025
Q3 		$43.9K Hold
20,500
– – ﹤0.01% 444
2025
Q2 		$46.1K Hold
20,500
– – ﹤0.01% 417
2025
Q1 		$28.1K Buy
+20,500
New +$28.2K ﹤0.01% 397

Other funds holding APYX

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return
HA
Huntleigh Advisors St. Louis, Missouri $714M AUM 62.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
RFWA
RPg Family Wealth Advisory Burlington, Massachusetts $600M AUM 36.53% 1-Year Est. Return

Joel Isaacson & Co's APYX Position: Q2 2026 in Review

Joel Isaacson & Co held its Apyx Medical (APYX) position steady in Q2 2026 at 20,500 shares worth $92K. The position accounts for ﹤0.01% of the portfolio, ranked #475.

Joel Isaacson & Co first reported a position in APYX in Q1 2025 and has held it in 6 quarters since. 20 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Joel Isaacson & Co held 20,500 shares of Apyx Medical worth $92K as of Q2 2026.
  • Joel Isaacson & Co left its Apyx Medical share count unchanged in Q2 2026.
  • Apyx Medical made up ﹤0.01% of Joel Isaacson & Co's portfolio in Q2 2026, its #475 holding.
  • Joel Isaacson & Co first reported a position in Apyx Medical in Q1 2025 and has held it in 6 quarters since.
  • 20 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Joel Isaacson & Co's 13F filing for Q2 2026, filed 4 Aug 2026.